Nanomedicine aims to find novel solutions for urgent biomedical needs. Despite this, one of the most challenging hurdles that nanomedicine faces is to successfully target therapeutic nanoparticles to cells of interest in vivo. As for any biomaterials, once in vivo, nanoparticles can interact with plasma biomolecules, forming new entities for which the name protein coronas (PCs) have been coined. The PC can influence the in vivo biological fate of a nanoparticle. Thus for guaranteeing the desired function of an engineered nanomaterial in vivo, it is crucial to dissect its PC in terms of formation and evolution within the body. In this contribution we will review the 'good' and 'bad' sides of the PC, starting from the scientific aspects to the technological applications.

Nanomedicine delivery: Does protein corona route to the target or off road?

MAIOLO, DANIELE;METRANGOLO, PIERANGELO;BALDELLI BOMBELLI, FRANCESCA
2015-01-01

Abstract

Nanomedicine aims to find novel solutions for urgent biomedical needs. Despite this, one of the most challenging hurdles that nanomedicine faces is to successfully target therapeutic nanoparticles to cells of interest in vivo. As for any biomaterials, once in vivo, nanoparticles can interact with plasma biomolecules, forming new entities for which the name protein coronas (PCs) have been coined. The PC can influence the in vivo biological fate of a nanoparticle. Thus for guaranteeing the desired function of an engineered nanomaterial in vivo, it is crucial to dissect its PC in terms of formation and evolution within the body. In this contribution we will review the 'good' and 'bad' sides of the PC, starting from the scientific aspects to the technological applications.
2015
Blood; drug delivery; nano-bio interaction; nanomedicine; nanoparticle; protein corona; surface; targeting; Materials Science (all); Bioengineering; Biomedical Engineering; Medicine (miscellaneous); Development; Education
File in questo prodotto:
File Dimensione Formato  
Nanomedicine 2015.pdf

Accesso riservato

Descrizione: Articolo principale
: Publisher’s version
Dimensione 3.67 MB
Formato Adobe PDF
3.67 MB Adobe PDF   Visualizza/Apri
Nanomedicine delivery-Does protein corona route to the target or off road_11311-970130_Metrangolo.pdf

accesso aperto

: Post-Print (DRAFT o Author’s Accepted Manuscript-AAM)
Dimensione 889.36 kB
Formato Adobe PDF
889.36 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11311/970130
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 84
  • ???jsp.display-item.citation.isi??? 80
social impact